Efficacy and Safety of Lenvatinib in Combination With Everolimus in Metastatic Renal Cell Carcinoma Resistant to Antiangiogenic Targeted Therapy: Russian Multicenter Observational Study ROSLERCM
Onkourologiya - Russian Federation
doi 10.17650/1726-9776-2019-15-3-56-69
Full Text
Open PDFAbstract
Available in full text
Date
October 9, 2019
Authors
Publisher
Publishing House ABV Press